Animal Vaccines Market: Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021

Report Code: ZMR-156 | Report Format : | Status : Upcoming |

Abstract

Vaccination has been one of the most important conciliations in disease prevention that has ever been developed.The effectiveness of vaccination is seen by the reduction in disease.Animal vaccines provide protection against various diseases such as rabies, feline panleukopenia, feline viral rhinotracheitis, feline calicivirus infection, canine distemper, canine parvovirus infection, and canine hepatitis. Hence, most of the animal doctors recommend vaccines depending on the type and severity of the disease.

Animal vaccines can be made available without large, controlled dispute studies that are mandatory prior to the release of human vaccines. Animal vaccines are controlled by the US Department of Agriculture, which hardly requires the vaccines to be shown to be safe and pure, and have a “reasonable expectation” of efficacy prior to their release.Nevertheless, the clinical relevancy or applicability of a particular vaccine may not necessarily be assured by the licensing process. This fact makes it easier for the manufacturers to provide animal vaccines and meet the rising demand in the global market.

Based on the type of vaccine, the global animal vaccines market is segmented as inactivated vaccines, toxoid vaccines, live attenuated vaccines, subunit vaccines, and others. The others segment is further sub-segmented as conjugate vaccines, recombinant vaccines, and DNA vaccines. Of which, the DNA vaccines segment is anticipated to account for the highest growth in the near future. On the basis of disease category, the global market is segmented as anthrax vaccines, rabies vaccine, brucellosis vaccine, DA2PPC vaccine, clostridium vaccine, and others. Based on the product type, the market is further segmented as companion animal, porcine, livestock, equine, poultry, aquaculture, and other animal vaccines. Owing to the rising number of pet owners worldwide, the companion animal segment proves to be largest and the fastest growing segment in the global market.

The growth of global animal vaccines market is expected to boost owing to the increase in the livestock population and frequent occurrence of livestock diseases. In addition, factors such as rising prevalence of zoonotic diseases, various initiatives were taken up by different government agencies and animal associations, and the introduction of new vaccine types also impact the growth of the market in a positive way. Moreover, technological innovations, growing awareness regarding animal health in the emerging countries, etc. are some other factors boosting the market growth.

Asia Pacific is experiencing the highest growth in the global market owing to its increased consumption and trade of meat. This trend is followed by China due to its rising consumption of meat. The global animal vaccines market is dominated by North America followed by Europe and Asia-Pacific.

Major players of the animal vaccines market include Merck Animal Health, Bayer Healthcare Novartis, Bimeda Inc., Ceva Sante Animale, Eli Lilly and Company, and Zoetis. Other key players who dominate the market are Sanofi-Aventis, Boehringer Ingelheim GmbH, and Virbac Inc.

Animal Vaccines Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Immuno-oncology Therapy Market by Therapy Type (Monoclonal Antibodies, Immune Checkpoint Inhibitors (PD-1/PD-L1 and CTLA-4), Immune System Modulators, and Cancer Vaccines) and by Therapeutic Areas, for Hospitals, Clinics, ASC’s and Cancer Research Institutes: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Jan-2018 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2534 | Report Format:

The report covers forecast and analysis for the immuno-oncology therapy market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the immuno-oncology therapy mar...Read More

Compounding Pharmacies Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2525 | Report Format:

Global Compounding Pharmacies Market: Overview Compounding is the knowledge of preparing and combining tailored medicines for users. These medicines are made on the basis of the prescription from the practitioner wherein, the separate ingredients are blended together according to the recommended...Read More

Antithrombin Market by (Source- Human, and Goat Milk; Application - Diagnostics, Therapeutics, and Research; Dosage Form- Liquid and Lyophilized): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2514 | Report Format:

The report covers forecast and analysis for the antithrombin market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the antithrombin market along with the imp...Read More

Alzheimer’s Drugs Market by Drug Class (Cholinergic, Memantine and Combined Drug), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Sales), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2513 | Report Format:

The report covers forecast and analysis for the Alzheimers drugs market on a global and regional level. The study provides historical data from 2014 along with a forecast from 2017 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the Alzheimers drugs market along ...Read More

Non-Invasive Prenatal Testing (NIPT) Market by Test Type (Panel 1, Panel 2 and Panel 3) and End-users (Hospitals, Diagnostic Centers and Maternity Clinics): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2512 | Report Format:

The report covers forecast and analysis for the non-invasive prenatal testing (NIPT) market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the non-invasive p...Read More

Choose License Type:
Latest Published Reports

View All Published Reports